Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Developmental psychologists at University of Oxford and Oxford Brookes University have raised enough money to provide outdoor baby and toddler weather gear for 70 local families. The rain-sets, provided at discount by Wet Wednesdays, have been distributed by volunteers from Home-Start Oxford to disadvantaged families struggling this winter.

Young child wearing wellington boots splashes in a puddle

The researchers were inspired to act when preliminary data from an ongoing study into the effects of the COVID-19 crisis on early development showed that babies and toddlers from disadvantaged backgrounds missed out on outside play during the spring 2020 lockdown. Dr Alex Hendry from the Department of Experimental Psychology came up with the fundraising idea and contacted Home-Start Oxford to see what she and her colleagues could do to help.

Dr Hendry said, 'Outdoor play is hugely important for early development. Exercising and exploring in the fresh air helps to promote thinking skills, and is key to good mental and physical health. When playgrounds and many other communal spaces were shut last spring, families without their own garden had limited options. This winter it looks like playgrounds and parks will stay open, but instead, families who are struggling financially are facing other barriers to outdoor play. Finding the extra cash for warm outdoor children’s clothes is difficult when money is tight – especially when you know they'll have outgrown it by next year.

'Lockdown restrictions also mean that most of the usual ways for parents to build and maintain support networks are unavailable. In this period of heightened isolation and stress, meeting up with another parent outside whilst little ones play has never been so important. We wanted to do something practical to help families make the most of the outdoors this winter.'

The full story is available on the Department of Experimental Psychology website

It is also featured on the University of Oxford website

Similar stories

PRINCIPLE Covid-19 treatments trial widens to under 50s and adds colchicine

Clinical Trials Coronavirus COVID-19 General Research

From today, the UK’s national priority platform trial of Covid-19 treatments for recovery at home launches its investigation of the gout drug colchicine, and expands for the first time to include adults of any age.

New data show vaccines reduce severe COVID-19 in older adults

Coronavirus COVID-19 Research

New data show both Oxford / AstraZeneca vaccine and the Pfizer-BioNTech vaccines significantly reduce severe COVID-19 in older adults.

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

Coronavirus COVID-19 General Research

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.